Skip to main content

Table 1 Correlations between TBL1XR1 expression and clinicopathologic characteristics of nasopharyngeal carcinoma patients

From: Transducin β-like 1 X-linked receptor 1 suppresses cisplatin sensitivity in Nasopharyngeal Carcinoma via activation of NF-κB pathway

Characteristics

No. cases

TBL1XR1 expression

Chi-square

Low or none

High

Test P-value

No. cases(%)

No. cases(%)

Gender

  

Male

79

41(51.9)

38(48.1)

0.611

Female

26

12(46.2)

14(53.8)

Age(years)

  

≤45

55

27(49.1)

28(50.9)

0.766

>45

50

26(52.0)

24(48.0)

Clinical Stage

  

I

2

2(100.0)

0(0.0)

 

II

21

18(85.7)

3(14.3)

0.001

III

49

22(44.9)

27(55.1)

IV

33

11(33.3)

22(66.7)

T classification

  

T1

3

3(100.0)

0(0.0)

 

T2

32

21(65.6)

11(34.4)

0.040

T3

44

19(43.2)

25(56.8)

T4

26

10(38.5)

16(61.5)

N classification

  

N0

26

18(69.2)

8(30.8)

 

N1

44

26(59.1)

18(40.9)

0.003

N2

22

5(22.7)

17(77.3)

N3

13

4(30.8)

9(69.2)

Patient survival

  

Alive

59

39(66.1)

20(33.9)

0.001

Deceased

46

14(30.4)

32(69.6)